Sub menu

Vaccines

Twinrix Junior (360/10)

Details for Twinrix Junior (360/10) (hepA/hepB) vaccine and its components.

Recently added

This page was added on 04 June 2018.

Updates made

This page was updated on [date-counter-updated-date]. View history of updates

Sponsor
GlaxoSmithKline Australia
Administration route
Intramuscular injection
Vaccine group
Combination vaccines
Description:

Registered for use in children aged 1–15 years.

Hepatitis A and hepatitis B vaccine combination vaccine.

Each 0.5 mL monodose vial or pre-filled syringe contains:

  • 360 ELISA units of inactivated hepatitis A virus (HM175 strain)
  • 10 µg recombinant hepatitis B surface antigen protein
  • 0.225 mg aluminium as aluminium phosphate and aluminium hydroxide

Also contains traces of:

  • formaldehyde
  • neomycin
  • trometamol
  • polysorbate 20

May contain yeast proteins.

For Product Information and Consumer Medicine Information about Twinrix (360/10) visit the Therapeutic Goods Administration website - external site.

Additional vaccine information

For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.

Allergy advice

May contain yeast proteins.

Related diseases
Hepatitis A
Hepatitis B

Page history

Last updated
Last reviewed

Help us improve the Australian Immunisation Handbook

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/vaccines/twinrix-junior-36010

All vaccines

Link copied

Link, share or bookmark directly to this section of the page.